Annovis BioAdvance News Portfolio News

Annovis Bio Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

By WebmasterApril 3, 2023November 1st, 2024No Comments

Annovis Bio Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Previous Post"Vesteck, Inc. Successfully Completes Five Clinical Cases"
Next PostRelmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results